U.S. markets open in 5 hours 27 minutes

Ginkgo Bioworks Holdings, Inc. (DNA)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
12.06+0.06 (+0.50%)
At close: 1:00PM EST
12.10 +0.04 (+0.33%)
After hours: 04:53PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Relative Strength Index (RSI)

Relative Strength Index (RSI)

Previous Close12.00
Bid0.00 x 800
Ask0.00 x 1100
Day's Range11.45 - 12.35
52 Week Range9.13 - 15.86
Avg. Volume7,761,092
Market Cap17.93B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for DNA

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Ginkgo Bioworks Holdings, Inc.
    MYGN: Lowering target price to $29.00MYRIAD GENETICS INC has an Investment Rating of HOLD; a target price of $29.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
    Fair Value
    Economic Moat
    5 days agoArgus Research
View more
  • American City Business Journals

    Joyn Bio expands Woodland ag-tech research operation

    Joyn Bio, a startup research company launched four years ago with $100 million in funding from Bayer and Ginkgo Bioworks Holdings Inc., is opening a new 6,000-square-foot greenhouse in Woodland to develop bioengineered microbes for farmers.

  • American City Business Journals

    Ginkgo Bioworks spinout launches with $78M to bioengineer beauty products

    After four years within the labs of Ginkgo Bioworks Holdings Inc. as an entrepreneur-in-residence, Jasmina Aganovic is striking out on her own as CEO of a new startup at the intersection of biotech and beauty: Arcaea.